Angiotensin II receptor antagonists: A new approach to blockade of the renin-angiotensin system
- 31 May 1994
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 127 (5) , 1388-1401
- https://doi.org/10.1016/0002-8703(94)90061-2
Abstract
No abstract availableKeywords
This publication has 92 references indexed in Scilit:
- Hypotensive activity of TCV-116, a newly developed angiotensin II receptor antagonist, in spontaneously hypertensive ratsLife Sciences, 1992
- Effects of losartan, a nonpeptide angiotensin II receptor antagonist, on cardiac hypertrophy and the tissue angiotensin II content in spontaneously hypertensive ratsLife Sciences, 1992
- Losartan, a specific angiotensin II receptor antagonist, increases angiotensin I and angiotensin II release from isolated rat hind legs: Evidence for locally regulated renin-angiotensin system in vascular tissueLife Sciences, 1992
- Competitive antagonism of pressor responses to angiotensin II and angiotensin III by the angiotensin II-1 receptor ligand losartanCanadian Journal of Physiology and Pharmacology, 1992
- Cloning and characterization of a human angiotensin II type 1 receptorBiochemical and Biophysical Research Communications, 1992
- Losartan, a nonpeptide angiotensin II (Ang II) receptor antagonist, inhibits neointima formation following balloon injury to rat carotid arteriesLife Sciences, 1991
- Identification of angiotensin II receptor subtypesBiochemical and Biophysical Research Communications, 1989
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Captopril and Renal AutoregulationNew England Journal of Medicine, 1983
- Captopril-Induced Functional Renal Insufficiency in Patients with Bilateral Renal-Artery Stenoses or Renal-Artery Stenosis in a Solitary KidneyNew England Journal of Medicine, 1983